GSK gets less from Zhifei shingles vaccine deal; to work on RSV
By Yadarisa Shabong (Reuters) – China’s Zhifei will pay GSK about 2.3 billion pounds ($2.9 billion) for the exclusive rights to distribute GSK’s shingles vaccine in China, the British drugmaker…
